Thoracoscopic-guided Azygos vein Catheterization and Port Implantation in a Child with End-stage Central Venous Access

2015 ◽  
Vol 16 (5) ◽  
pp. e97-e98
Author(s):  
Tarik Umutoglu ◽  
Gokhan Gundogdu ◽  
Ufuk Topuz ◽  
Mefkur Bakan
2017 ◽  
Vol 2017 ◽  
pp. 1-5 ◽  
Author(s):  
Gernot Rott ◽  
Frieder Boecker

We report on a patient who was referred for port implantation with a two-chamber pacemaker aggregate on the right and total occlusion of the central veins on the left side. Venous access for port implantation was performed via left side puncture of the horizontal segment of the anterior jugular vein system (AJVS) and insertion of the port catheter using a crossover technique from the left to the right venous system via the jugular venous arch (JVA). The clinical significance of the AJVS and the JVA for central venous access and port implantation is emphasised and the corresponding literature is reviewed.


2017 ◽  
Vol 24 ◽  
pp. 1-4 ◽  
Author(s):  
David P. Mysona ◽  
Randi L. Lassiter ◽  
Kenneth C. Walters ◽  
Walter L. Pipkin ◽  
Robyn M. Hatley

2019 ◽  
Vol 76 (1) ◽  
pp. 182-192
Author(s):  
Teresa Schreckenbach ◽  
Indra Münch ◽  
Hanan El Youzouri ◽  
Wolf Otto Bechstein ◽  
Nils Habbe

2006 ◽  
Vol 42 (4) ◽  
pp. 427-433 ◽  
Author(s):  
A.F. Rodrigues ◽  
I.D.M. van Mourik ◽  
K. Sharif ◽  
D.J. Barron ◽  
J.V. de Giovanni ◽  
...  

Author(s):  
Lingyun Tian ◽  
Wan Li ◽  
Yanan Su ◽  
Huimin Gao ◽  
Qiuhong Yang ◽  
...  

Abstract Objective To identify the potential associations of patient-, treatment-, and central venous access device (CVAD)-related factors with the CVAD-related thrombosis (CRT) risk in hospitalized children. Methods A systematic search of PubMed, EMBASE, Web of Science, the Cochrane Library, China National Knowledge Infrastructure, Wanfang, and VIP database was conducted. RevMan 5.3 and Stata 12.0 statistical software were employed for data analysis. Results In terms of patient-related factors, the patient history of thrombosis (odds ratio [OR] = 3.88, 95% confidence interval [CI]: 2.57–5.85), gastrointestinal/liver disease (OR = 1.85, 95% CI: 0.99–3.46), hematologic disease (OR = 1.45, 95% CI: 1.06–1.99), and cancer (OR = 1.58, 95% CI: 1.01–2.48) were correlated with an increased risk of CRT. In terms of treatment-related factors, parenteral nutrition (PN)/total PN (OR = 1.70, 95% CI: 1.21–2.39), hemodialysis (OR = 2.17, 95% CI: 1.34–3.51), extracorporeal membrane oxygenation (OR = 1.51, 95% CI: 1.31–1.71), and cardiac catheterization (OR = 3.92, 95% CI: 1.06–14.44) were associated with an increased CRT risk, while antibiotics (OR = 0.46, 95% CI: 0.32–0.68) was associated with a reduced CRT risk. In terms of the CVAD-related factors, CRT risk was more significantly increased by peripherally inserted central catheter than tunneled lines (OR = 1.81, 95% CI: 1.15–2.85) or totally implantable venous access port (OR = 2.81, 95% CI: 1.41–5.60). And subclavian vein catheterization significantly contributed to a lower CRT risk than femoral vein catheterization (OR = 0.36, 95% CI: 0.14–0.88). Besides, multiple catheter lines (OR = 4.06, 95% CI: 3.01–5.47), multiple catheter lumens (OR = 3.71, 95% CI: 1.99–6.92), central line-associated bloodstream infection (OR = 2.66, 95% CI: 1.15–6.16), and catheter malfunction (OR = 1.65, 95% CI: 1.07–2.54) were associated with an increased CRT risk. Conclusion The exact identification of the effect of risk factors can boost the development of risk assessment tools with stratifying risks.


2005 ◽  
Vol 6 (4) ◽  
pp. 196-199 ◽  
Author(s):  
J. Harney ◽  
S. Ahmed ◽  
K. Faccini ◽  
J. Raymond ◽  
P. Lind ◽  
...  

End-stage renal failure (ESRF) patients can develop cancer before or after kidney disease occurs. Cancer chemotherapy often needs to be administered via the sort of central venous catheter that is normally avoided in ESRF care. Three cases are presented in which ESRF patients received chemotherapy for cancer via existing hemodialysis fistulas, and the consequences of central venous access in a fourth patient are discussed.


Author(s):  
Wongsakorn Chaochankit ◽  
Surasak Sangkhathat

The central venous catheter (CVC) has become an integral part of various long term parenteral therapies including chemotherapy and parenteral nutrition. In pediatric patients with a long term CVC, multiple repeated accesses and catheter-related complications may lead to difficulty in reestablishment of a line. Strategies in CVC management in these patients should begin with choosing an appropriate catheter according to its purpose, choosing the right access site and prompt treatment of potential complications, especially catheter-related thrombosis. In patients with severe restriction of the superior vena cava and its tributaries, end-stage central venous access is diagnosed. Management of this situation requires a multidisciplinary team and alternative routes of venous access including access through small collateral veins, or through an unusual vein such as the hepatic vein or a gonadal vein, and/or use of alternative surgical techniques. This article provides a comprehensive review regarding the current approach and surgical options in pediatric patients with end-stage central venous access.


1998 ◽  
Vol 2 (1) ◽  
pp. 38-40
Author(s):  
Franco Tesio ◽  
Hamurabi De Baz ◽  
Giacomo Panarello

Sign in / Sign up

Export Citation Format

Share Document